RESEARCH PAPER
Secondary analysis of an RCT on Emergency Department- Initiated Tobacco Control: Repeatedly assessed point-prevalence abstinence up to 12 months and extension of results through a 10-year follow-up
 
More details
Hide details
1
Department of Anesthesiology and Intensive Care Medicine, Charité– Universitätsmedizin Berlin, Berlin, Germany
2
Center for Cancer Prevention and Control Research, UCLA Fielding School of Public Health, Los Angeles, United States
3
Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
CORRESPONDING AUTHOR
Bruno Neuner   

Charité– Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Publish date: 2019-04-05
 
Tob. Induc. Dis. 2019;17(April):26
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Emergency departments (EDs) are opportune places for tobacco control interventions. The ‘Tobacco Control in an Urban Emergency Department’ (TED) study, ISRCTN41527831, originally evaluated the effect of motivational interviewing on-site plus up to four booster telephone calls on 12-month abstinence. This study’s aim was to evaluate the effect of the intervention on 7-day point-prevalence abstinence at 10 years follow-up (primary outcome) as well as on repeated point-prevalence abstinence at 1, 3, 6, 12 months and at 10 years (continual smoking abstinence, secondary outcome).

Methods:
At the 10 years follow-up and after informed consent, study participants responded to a mailed questionnaire. The primary outcome was analyzed in observed-only and in all-cases analyses. The secondary outcomes were analyzed using a multiple adjusted GLMM for binary outcomes.

Results:
Out of 1012 TED-study participants, 986 (97.4%) were alive and 231 (23.4% of 986) responded to the follow-up at 10 years. For observed-only and all-cases analyses, the effect of the baseline intervention on 7-day point-prevalence abstinence at the 10 years follow-up was statistically non-significant. However, when taking into account all repeated measures, the intervention significantly influenced continual abstinence with odds ratio 1.32 (95% CI: 1.01–1.73; p=0.042). Baseline motivation, perceived self-efficacy to stop smoking, and nicotine dependency were independently associated with long-term continual smoking abstinence (all p<0.05).

Conclusions:
A conventional analysis failed to confirm a significant effect of the EDinitiated tobacco control intervention on the point-prevalence abstinence at 10 years. Results from a more integrative analysis nonetheless indicated an enduring intervention effect on continual abstinence among smokers first encountered in the emergency department setting 10 years earlier.

ACKNOWLEDGEMENTS
WJ McCarthy was supported by National Institute of Health grant U54 CA 143931 during the time that this article was written. We acknowledge further support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charité– Universitätsmedizin Berlin. The authors thank two anonymous reviewers for their helpful comments on an earlier version of this manuscript.
CONFLICTS OF INTEREST
The authors declare that they have no competing interests, financial or otherwise, related to the current work. C Spies received funding from Deutsche Krebshilfe (DKH-111507) during the conduct of the present work. C Spies also received funding outside the present work from European Union Seventh Framework research program [FP7/2007- 2013], under the grant agreement No. HEALTH-F2-2014-60246, BioCog. C Spies reports grants outside this work from: Dr F. Köhler Chemie GmbH, AppAdventure, J&P Medical Research Ltd., Pharmaceutical Research Associates GmbH, Delcath Systems Inc., INC Research UK Ltd., La Jolla Pharmaceutical Company, Aridis Pharmaceutical Inc., B. Braun Melsungen AG, Drägerwerk AG & Co. KGaA, Grünenthal GmbH, Infectopharm GmbH, Sedana Medical Ltd., Arbeitsgemeinschaft industrieller Forschungsvereinigungen ‘Otto von Guericke’ e.V., Berufsverband Deutscher Anästhesisten e.V., Deutsche Forschungsgemeinschaft, Deutsches Zentrum für Luftund Raumfahrt e.V., Einstein Stiftung Berlin, European Society of Anaesthesiology, Gemeinsamer Bundesausschuss, Inneruniversitäre Forschungsförderung, Projektträger im DLR, Stifterverband, WHOCC, Westfälische Wilhelms-Universität Münster/DFG, AbbVie Deutschland GmbH & Co. KG, Aguettant Deutschland GmbH, MAQUET Vertrieb und Service Deutschland GmbH, Orion Pharma GmbH, Philips Electronics Nederland B.V., Sintetica GmbH, Baxter Deutschland GmbH, Biotest AG, Cytosorbents Europe GmbH, Edwards Lifesciences Germany GmbH, Fresenius Medical Care, Grünenthal GmbH, Masimo Europe Ltd., Medtronic GmbH, Pfizer Pharma PFE GmbH, European Commission, Bundesministerium für Umwelt, Naturschutz und nukleare Sicherheit. C Spies also reports personal fees from Georg Thieme Verlag outside this work. In addition, C Spies has a patent 10 2014 215 211.9 pending, a patent Application No. PCT/EP2015/067730 pending to Graft Gesellschaft von Architekten mbH, and a patent Application No. PCT/ EP2015/067731 pending to Graft Gesellschaft von Architekten mbH. The rest of the authors have also completed and submitted an ICMJE form for disclosure of potential conflicts of interest.
FUNDING
The Laocoon study was financed by the German Cancer Foundation (Deutsche Krebshilfe), Bonn, Germany (Grant DKH-111507), and by institutional resources of the Charité–Universitätsmedizin Berlin.
PROVENANCE AND PEER REVIEW
Not commissioned; externally peer reviewed.
 
REFERENCES (36)
1.
CB Irvin, Wyer PC, Gerson LW, et al. Preventive care in the emergency department, Part II: Clinical preventive services--an emergency medicine evidence-based review. Acad Emerg Med. 2008;7:1042-1054. doi:10.1111/j.1553-2712.2000.tb02098.x
 
2.
Rhodes KV, Gordon JA, Lowe RA, et al. Preventive care in the emergency department, Part I: Clinical preventive services--are they relevant to emergency medicine? Acad Emerg Med. 2008;7:1036-1041. doi:10.1111/j.1553-2712.2000.tb02097.x
 
3.
Bernstein SL, Boudreaux ED, Cydulka RK, et al. Tobacco control interventions in the emergency department: a joint statement of emergency medicine organizations. Ann Emerg Med. 2006;48:e417-e426. doi:10.1016/j.annemergmed.2006.02.018
 
4.
Lemhoefer C, Rabe GL, Wellmann J, et al. Emergency Department-Initiated Tobacco Control: Update of a Systematic Review and Meta-Analysis of Randomized Controlled Trials. Prev Chronic Dis. 2017;14:E89. doi:10.5888/pcd14.160434
 
5.
Murray RP, Anthonisen NR, Connett JE, et al. Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. J Clin Epidemiol. 1998;51:1317-1326. doi:10.1016/s0895-4356(98)00120-6
 
6.
McCarthy DE, Ebssa L, Witkiewitz K, Shiffman S. Paths to tobacco abstinence: A repeated-measures latent class analysis. J Consult Clin Psychol. 2015;83:696-708. doi:10.1037/ccp0000017
 
7.
West R. Tobacco smoking: Health impact, prevalence, correlates and interventions. Psychol Health. 2017;32:1018-1036. doi:10.1080/08870446.2017.1325890
 
8.
Neuner B, Weiss-Gerlach E, Miller P, Martus P, Hesse D, Spies C. Emergency department-initiated tobacco control: a randomised controlled trial in an inner city university hospital. Tob Control. 2009;18:283-293. doi:10.1136/tc.2008.028753
 
9.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Addiction. 1991;86:1119-1127. doi:10.1111/j.1360-0443.1991.tb01879.x
 
10.
Keller S, Velicer WF, Prochaska JO. Das Transtheoretische Modell - eine Übersicht (The transtheoretical model - a summary). In Keller S, ed. Das Transtheoretische Modell in Forschung und Praxis (The transtheoretical model in research and practice). Freiburg, Germany: Lambertus: 1999: 17-44.
 
11.
Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol. 1992;47:1102-1114. doi:10.1037//0003-066x.47.9.1102
 
12.
Piccinelli M, Tessari E, Bortolomasi M. et al. Efficacy of the alcohol use disorders identification test as a screening tool for hazardous alcohol intake and related disorders in primary care: a validity study. BMJ. 1997;314:420-424. doi:10.1136/bmj.314.7078.420
 
13.
Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Addiction. 1989;84:791-799. doi:10.1111/j.1360-0443.1989.tb03059.x
 
14.
Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17. doi:10.1186/1751-0473-3-17
 
15.
Newcombe PJ, Connolly S, Seaman S, Richardson S, Sharp SJ. A two-step method for variable selection in the analysis of a case-cohort study. Int J Epidemiol. 2018;47:597-604. doi:10.1093/ije/dyx224
 
16.
Miller WR, Rollnick S. Evoking the Person's Own Motivation. In: Motivational Interviewing: Helping People Change. New York: The Guilford Press; 2012: 167-182.
 
17.
Miller WR, Rollnick S. Evoking Hope and Confidence. In: Motivational Interviewing: Helping People Change. New York, London: The Guilford Press; 2012: 212-230.
 
18.
Jones M, Hockey R, Mishra GD, Dobson A. Visualising and modelling changes in categorical variables in longitudinal studies. BMC Med Res Methodol. 2014;14:32. doi:10.1186/1471-2288-14-32
 
19.
Gabriel KR. Ante-dependence Analysis of an Ordered Set of Variables. Ann Math Stat. 1962;33:201-212. doi:10.1214/aoms/1177704724
 
20.
Kenward MG. A Method for Comparing Profiles of Repeated Measurements. Appl Statist. 1987;36:296-308. doi:10.2307/2347788
 
21.
Leung DY, Au DW, Lam TH, Chan SS. Predictors of long-term abstinence among Chinese smokers following treatment: the role of personality traits. Asian Pac J Cancer Prev 2013;14:5351-5354. doi:10.7314/apjcp.2013.14.9.5351
 
22.
Nohlert E, Ohrvik J, Tegelberg A, Tillgren P, Helgason AR. Long-term follow-up of a high- and a low-intensity smoking cessation intervention in a dental setting--a randomized trial. BMC Public Health. 2013;13:592. doi:10.1186/1471-2458-13-592
 
23.
Peterson AV, Marek PM, Kealey KA, Bricker JB, Ludman EJ, Heffner JL. Does Effectiveness of Adolescent Smoking-Cessation Intervention Endure Into Young Adulthood? 7-Year Follow-Up Results from a Group-Randomized Trial. PLoS One. 2016;11:e0146459. doi:10.1371/journal.pone.0146459
 
24.
Yudkin P, Hey K, Roberts S, Welch S, Murphy M, Walton R. Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch. BMJ. 2003;327:28-29. doi:10.1136/bmj.327.7405.28
 
25.
Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence, clinical practice guideline; Public Health Service. Rockville, MD: U.S. Department of Health and Human Services: 2010.
 
26.
Belita E, Sidani S. Attrition in Smoking Cessation Intervention Studies: A Systematic Review. Can J Nurs Res. 2015;47:21-40. doi:10.1177/084456211504700404
 
27.
Honjo K, Iso H, Inoue M, Tsugane S. Smoking cessation: predictive factors among middle-aged Japanese. Nicotine Tob Res. 2010;12:1050-1054. doi:10.1093/ntr/ntq143
 
28.
Okuyemi KS, Thomas JL, Warren J, Guo H, Ahluwalia JS. Relationship between smoking reduction and cessation among light smokers. Nicotine Tob Res. 2010;12:1005-1010. doi:10.1093/ntr/ntq138
 
29.
Zethof D, Nagelhout GE, de Rooij M, et al. Attrition analysed in five waves of a longitudinal yearly survey of smokers: findings from the ITC Netherlands survey. Eur J Public Health. 2016;26:693-699. doi:10.1093/eurpub/ckw037
 
30.
Kale D, Gilbert HM, Sutton S. Are predictors of making a quit attempt the same as predictors of 3-month abstinence from smoking? Findings from a sample of smokers recruited for a study of computer-tailored smoking cessation advice in primary care. Addiction. 2015;110:1653-1664. doi:10.1111/add.12972
 
31.
Neves RD, Avila GK, Oliveira FB, Sampaio JAF. Impact of Myocardial Revascularization Method on Smoking Cessation: Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention. Braz J Cardiovasc Surg. 2017;32:383-389. doi:10.21470/1678-9741-2017-0041
 
32.
Okoli CT, Khara M. Smoking cessation outcomes and predictors among individuals with co-occurring substance use and/or psychiatric disorders. J Dual Diagn. 2014;10:9-18. doi:10.1080/15504263.2013.866860
 
33.
Gerber Y, Koren-Morag N, Myers V, Benyamini Y, Goldbourt U, Drory Y. Long-term predictors of smoking cessation in a cohort of myocardial infarction survivors: a longitudinal study. Eur J Cardiovasc Prev Rehabil. 2011;18:533-541. doi:10.1177/1741826710389371
 
34.
Neuner B, Fleming M, Born R, et al. Predictors of loss to follow-up in young patients with minor trauma after screening and written intervention for alcohol in an urban emergency department. J Stud Alcohol Drugs. 2007;68:133-140. doi:10.15288/jsad.2007.68.133
 
35.
Paul M, George PS, Mathew A. Patient and disease related factors associated with lost-to follow-up/drop-outs of cervical cancer patients: a study at a Major Cancer Hospital in South India. Asian Pac J Cancer Prev. 2010;11:1529-1534.
 
36.
Strecher VJ, McClure J, Alexander G, et al. The role of engagement in a tailored web-based smoking cessation program: randomized controlled trial. J Med Internet Res. 2008;10:e36. doi:10.2196/jmir.1002
 
eISSN:1617-9625